{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:56:05Z","timestamp":1776830165442,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drudis.2017.01.010","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T20:43:21Z","timestamp":1485290601000},"page":"1134-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?"],"prefix":"10.1016","volume":"22","author":[{"given":"Alessandro","family":"Dalpiaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2017.01.010_bib0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery strategies: review of recent advances and business prospects","volume":"5","author":"Kalepua","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drudis.2017.01.010_bib0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/90761","article-title":"ADMET: turning chemicals into drugs","volume":"19","author":"Hodgson","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2017.01.010_bib0015","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/jps.24088","article-title":"Physicochemical properties, form, and formulation selection strategy for a biopharmaceutical classification system class II preclinical drug candidate","volume":"103","author":"Lohani","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2017.01.010_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(01)00098-9","article-title":"Amorphous pharmaceutical solids: preparation, characterization and stabilization","volume":"48","author":"Yu","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2017.01.010_bib0025","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1039\/C6CC02943D","article-title":"Pharmaceutical cocrystals: walking the talk","volume":"52","author":"Bolla","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.drudis.2017.01.010_bib0030","series-title":"Carbohydrates\u2013Comprehensive Studies on Glycobiology and Glycotechnology","first-page":"81","article-title":"Investigation of carbohydrates and their derivatives as crystallization modifiers","author":"Jamp\u00edlek","year":"2012"},{"key":"10.1016\/j.drudis.2017.01.010_bib0035","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/cg060742p","article-title":"Cocrystals of piroxicam with carboxylic acids","volume":"7","author":"Childs","year":"2007","journal-title":"Crystal Growth Des."},{"key":"10.1016\/j.drudis.2017.01.010_bib0040","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/cg3002948","article-title":"Polymorphs, salts, and co-crystals: what's in a name?","volume":"12","author":"Aitipamula","year":"2012","journal-title":"Crystal Growth Des."},{"key":"10.1016\/j.drudis.2017.01.010_bib0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1039\/b505883j","article-title":"Building co-crystals with molecular sense and supramolecular sensibility","volume":"7","author":"Aaker\u00f6y","year":"2005","journal-title":"Cryst. Eng. Commun."},{"key":"10.1016\/j.drudis.2017.01.010_bib0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1557\/mrs2006.206","article-title":"Pharmaceutical cocrystals: an emerging approach to physical property enhancement","volume":"31","author":"Jones","year":"2006","journal-title":"MRS Bull."},{"key":"10.1016\/j.drudis.2017.01.010_bib0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.addr.2016.04.022","article-title":"Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5","volume":"101","author":"Kuminek","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2017.01.010_bib0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1039\/C5CC08216A","article-title":"Pharmaceutical cocrystals: along the path to improved medicines","volume":"52","author":"Duggirala","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.drudis.2017.01.010_bib0065","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.3390\/molecules16053740","article-title":"Crystallization products of risedronate with carbohydrates and their substituted derivatives","volume":"16","author":"Kos","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2017.01.010_bib0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2012.10.043","article-title":"Pharmaceutical cocrystals and poorly soluble drugs","volume":"453","author":"Thakuria","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2017.01.010_bib0075","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/acs.molpharmaceut.5b00020","article-title":"Cocrystals of hydrochlorothiazide: solubility and diffusion\/permeability enhancements through drug\u2013coformer interactions","volume":"12","author":"Sanphui","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2017.01.010_bib0080","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1002\/jps.24640","article-title":"Solubilization in biorelevant media and its prediction from drug solubilization","volume":"104","author":"Lipert","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2017.01.010_bib0085","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/17425255.2014.942281","article-title":"Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics","volume":"10","author":"Shan","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.drudis.2017.01.010_bib0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2017.01.010_bib0095","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1021\/mp400176y","article-title":"Formulation of a Danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability","volume":"10","author":"Childs","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2017.01.010_bib0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2013.12.016","article-title":"Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs","volume":"87","author":"De Smet","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2017.01.010_bib0105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijbiomac.2014.12.038","article-title":"Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac","volume":"74","author":"Ganesha","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.drudis.2017.01.010_bib0110","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1039\/c3ce41017j","article-title":"Simultaneously enhancing the solubility and permeability of acyclovir by crystal engineering approach","volume":"15","author":"Yan","year":"2013","journal-title":"Cryst. Eng. Commun."},{"key":"10.1016\/j.drudis.2017.01.010_bib0115","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.cgd.6b00552","article-title":"Improving the membrane permeability of 5-fluorouracil via cocrystallization","volume":"16","author":"Dai","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.drudis.2017.01.010_bib0120","series-title":"Web of Science\u2122 Core Collections","author":"Thomson Reuters","year":"2016"},{"key":"10.1016\/j.drudis.2017.01.010_bib0125","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/cg201510n","article-title":"Cocrystal systems of pharmaceutical interest: 2010","volume":"12","author":"Brittain","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.drudis.2017.01.010_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jps.23402","article-title":"Pharmaceutical cocrystals: the coming wave of new drug substances","volume":"102","author":"Brittain","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2017.01.010_bib0135","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1021\/cg301114f","article-title":"Cocrystal systems of pharmaceutical interest: 2011","volume":"12","author":"Brittain","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.drudis.2017.01.010_bib0140","series-title":"Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological\/Biological Entities) Q11","year":"2012"},{"key":"10.1016\/j.drudis.2017.01.010_bib0145","series-title":"Reflection Paper on the Use of Cocrsytals of Active Substances in Medicinal Products","year":"2015"},{"key":"10.1016\/j.drudis.2017.01.010_bib0150","series-title":"Quality Guidelines","year":"2017"},{"key":"10.1016\/j.drudis.2017.01.010_bib0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/mp500826y","article-title":"Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently?","volume":"12","author":"Ferretti","year":"2015","journal-title":"Mol. Pharm."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617300351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617300351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:29:32Z","timestamp":1761222572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644617300351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1359644617300351"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2017.01.010","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2017.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}